Showing results (731-740 of 5,100) with videos related to
Sort By:
Pageof 510
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|July 4, 2013
Bioengineered nanoparticles for siRNA deliveryKristen L Kozielski, Stephany Y Tzeng, Jordan J GreenHellenic Journal of Nuclear Medicine|March 14, 2012
Positron emission tomography in the prediction of inflammation in children with human immunodeficiency virus related bronchiectasisRefiloe Masekela, Harlem Gongxeka, Robin J Green, et al.Human Reproduction (Oxford, England)|November 30, 2014
Insulin-like growth factor 1 increases apical fibronectin in blastocysts to increase blastocyst attachment to endometrial epithelial cells in vitroCharmaine J Green, Stuart T Fraser, Margot L DayCanadian Journal of Diabetes|December 3, 2014
Physiological and glycemic responses following acute ingestion of a popular functional drink in patients with type 1 diabetesTolulope Olateju, Joseph Begley, Daniel J Green, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|July 26, 2015
Significant differences in fecal microbiota are associated with various stages of glucose tolerance in African American male veteransIrina Ciubotaru, Stefan J Green, Subhash Kukreja, et al.Nucleic Acids Research|November 26, 2015
Signature motifs of GDP polyribonucleotidyltransferase, a non-segmented negative strand RNA viral mRNA capping enzyme, domain in the L protein are required for covalent enzyme-pRNA intermediate formationJulie Neubauer, Minako Ogino, Todd J Green, et al.Biorxiv : the Preprint Server for Biology|November 11, 2020
Structure of nonstructural protein 1 from SARS-CoV-2Lauren K Clark, Todd J Green, Chad M PetitCell Motility and the Cytoskeleton|January 1, 1986
Relationship between intermediate filaments and microfilaments in cultured fibroblasts: evidence for common foci during cell spreadingK J Green, J C Talian, R D GoldmanThrombosis Research|May 1, 1985
Induction of a sustained fibrinolytic response by BRL 26921 in vitroR Fears, J Green, R A Smith, et al.Journal of Drugs in Dermatology : JDD|August 20, 2019
Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With PsoriasisLawrence J. Green, Paul S. Yamauchi, Leon H. KircikPageof 510